Il-6 And Other Biomarkers As Predictors Of Severity In Covid-19

N Broman, K Rantasärkkä,T Feuth, M Valtonen, M Waris,U Hohenthal,E Rintala,A Karlsson, H Marttila,V Peltola,T Vuorinen,J Oksi

ANNALS OF MEDICINE(2021)

引用 71|浏览18
暂无评分
摘要
ObjectiveCytokine release syndrome is suggested to be the most important mechanism triggering acute respiratory distress syndrome and end organ damage in COVID-19. The severity of disease may be measured by different biomarkers.MethodsWe studied markers of inflammation and coagulation as recorded in 29 patients on admission to the hospital in order to identify markers of severe COVID-19 and need of ICU.ResultsPatients who were eventually admitted to ICU displayed significantly higher serum levels of interleukin-6 (IL-6), C-reactive protein (CRP), and procalcitonin. No statistical differences were found between the groups in median levels of lymphocytes, D-dimer or ferritin.ConclusionsIL-6 and CRP were the strongest predictors of severity in hospitalized patients with COVID-19.
更多
查看译文
关键词
COVID-19, interleukin, interferon, inflammatory phase, tocilizumab, cytokine storm, cytokine release syndrome
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要